MEN significantly increases the risk of developing certain types of cancer, particularly those affecting endocrine glands. In MEN1, there is a heightened risk of pancreatic neuroendocrine tumors, while MEN2 is closely associated with medullary thyroid carcinoma and pheochromocytomas. Understanding the genetic basis and clinical presentation of MEN is crucial in the context of cancer prevention and treatment.
